Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Nov 04, 2016 $1.51 $1.58 $1.45 $1.55 168 800
Nov 03, 2016 $1.57 $1.59 $1.50 $1.50 211 000
Nov 02, 2016 $1.60 $1.67 $1.50 $1.58 165 500
Nov 01, 2016 $1.79 $1.80 $1.55 $1.58 426 000
Oct 31, 2016 $1.73 $1.81 $1.72 $1.77 123 800
Oct 28, 2016 $1.90 $1.97 $1.70 $1.71 445 700
Oct 27, 2016 $2.00 $2.05 $1.90 $1.91 227 300
Oct 26, 2016 $2.02 $2.02 $1.92 $1.98 101 800
Oct 25, 2016 $1.97 $2.04 $1.92 $2.02 218 100
Oct 24, 2016 $1.94 $2.01 $1.88 $1.96 170 500
Oct 21, 2016 $1.93 $1.95 $1.89 $1.93 91 200
Oct 20, 2016 $1.85 $1.94 $1.85 $1.93 77 200
Oct 19, 2016 $1.87 $1.94 $1.83 $1.92 130 400
Oct 18, 2016 $1.85 $1.95 $1.80 $1.89 151 400
Oct 17, 2016 $1.91 $1.95 $1.77 $1.82 427 900
Oct 14, 2016 $2.00 $2.01 $1.87 $1.90 487 900
Oct 13, 2016 $2.00 $2.01 $1.96 $2.00 149 800
Oct 12, 2016 $1.97 $2.01 $1.93 $2.00 186 200
Oct 11, 2016 $1.97 $2.01 $1.94 $1.99 274 300
Oct 10, 2016 $1.98 $2.02 $1.95 $1.98 351 200
Oct 07, 2016 $2.05 $2.06 $1.97 $1.99 347 600
Oct 06, 2016 $2.15 $2.15 $1.98 $2.04 741 800
Oct 05, 2016 $2.11 $2.12 $2.02 $2.08 660 700
Oct 04, 2016 $2.18 $2.19 $2.05 $2.08 1 492 200
Oct 03, 2016 $2.00 $2.01 $1.96 $1.96 137 500
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT